Season 3, Episode 8 (Microneedling for AA, Periodontitis and AA Risk, Microneedling in AGA, Hair Loss in Transgender Patients)
Manage episode 349342383 series 3312560
STUDIES REFERENCED
ROLE OF CORTICOSTEROIDS IN THE JAK INHIBITOR ERA
Licata G et al (starts at 7:21). Management of alopecia areata in JAK-inhibitors era: are systemic and topical corticosteroids still useful? Int J Dermatol. 2022 Nov 13.
ALOPECIA AREATA AND PERIODONTITIS
Kim JS et al (starts at 17:15). Periodontitis and risk of alopecia areata: A nationwide population-based cohort study in Korea. J Eur Acad Dermatol Venereol. 2022 Nov 17.
ALOPECIA AREATA AND MICRONEEDLING
Arora A et al (starts at 23:33). Comparative Efficacy of Injection Triamcinolone Acetonide given Intralesionally and through Microneedling in Alopecia areata. Int J Trichology. 2022 Sep-Oct;14(5):156-161.
Chandrashekar BS et al (starts at 27:42). Alopecia areata-successful outcome with microneedling and triamcinolone acetonide. J Cutan Aesthet Surg. 2014 Jan;7(1):63-4.
HAIR LOSS IN TRANSGENDER INDIVIDUALS
C Cocchetti et al (starts at 32:04). Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI). J Endocrinol Invest. 2022 Nov 8.
MICRONEEDLING TO TREAT ANDROGENETIC ALOPECIA
Lingling Jia et al (starts at 38:21). Effects of microneedling with 5% minoxidil topical solution combination therapy in treatment of androgenetic alopecia. J Cosmet Dermatol. 2022 Jul 21.
Dhurat R et al (starts at 40:18). A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013 Jan;5(1):6-11.
Liang X et al (starts at 43:49). Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial. Front Med (Lausanne). 2022 Jul 11;9:905140.
57 episodes